For most people, an FDA-approved brand or oral option is now the safer path
Healthcare providers typically monitor hemoglobin A1c, fasting blood glucose, lipid panels, kidney function tests (creatinine, eGFR, UACR), and liver function tests to assess treatment efficacy and safety
[PMC free article: PMC2173981] [PubMed: 12486113] 353
Next, explain that more robust long-term data have not confirmed a significant increase in pancreatic cancer rates among GLP-1 users
Experimentation with these peptides encourages individuals to treat their physical health as a site of informal laboratory experiments
Some people with PCOS and high BMI also struggle with lipedema or lymphedema, which have improved in many cases with the use of GLP-1 agonist medications